Binding to the PDZ binding motif of G protein-coupled receptors through PDZ domain, SNX27 interferes with its recycling from the endosome to cell membrane, and thus SNX27 is expected to be the next promising tumor therapeutic target34. This evidence concerns the gene SNX27 and neoplasm.